142 related articles for article (PubMed ID: 32012463)
1. Synthesis, Molecular Docking, and Preliminary Evaluation of 2-(1,2,3-Triazoyl)benzaldehydes As Multifunctional Agents for the Treatment of Alzheimer's Disease.
Costa GP; Baldinotti RSM; Fronza MG; Nascimento JER; Dias ÍFC; Sonego MS; Seixas FK; Collares T; Perin G; Jacob RG; Savegnago L; Alves D
ChemMedChem; 2020 Apr; 15(7):610-622. PubMed ID: 32012463
[TBL] [Abstract][Full Text] [Related]
2. Rational design, cognition and neuropathology evaluation of QTC-4-MeOBnE in a streptozotocin-induced mouse model of sporadic Alzheimer's disease.
Fronza MG; Baldinotti R; Martins MC; Goldani B; Dalberto BT; Kremer FS; Begnini K; Pinto LDS; Lenardão EJ; Seixas FK; Collares T; Alves D; Savegnago L
Sci Rep; 2019 May; 9(1):7276. PubMed ID: 31086208
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease.
Tripathi A; Choubey PK; Sharma P; Seth A; Saraf P; Shrivastava SK
Bioorg Chem; 2020 Jan; 95():103506. PubMed ID: 31887472
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease.
Amin KM; Abdel Rahman DE; Abdelrasheed Allam H; El-Zoheiry HH
Bioorg Chem; 2021 May; 110():104792. PubMed ID: 33799178
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro evaluation of vanillin derivatives as multi-target therapeutics for the treatment of Alzheimer's disease.
Blaikie L; Kay G; Kong Thoo Lin P
Bioorg Med Chem Lett; 2020 Nov; 30(21):127505. PubMed ID: 32822761
[TBL] [Abstract][Full Text] [Related]
7. 2',6'-dihydroxy-4'-methoxy Dihydrochalcone Improves the Cognitive Impairment of Alzheimer's Disease: A Structure-activity Relationship Study.
Gonçalves AE; Malheiros Â; Casarin CA; de França L; Palomino-Salcedo DL; Ferreira LLG; Andricopulo AD; Dávila-Rodríguez MJ; Lacava LC; de Oliveira AS; de Souza MM
Curr Top Med Chem; 2021; 21(13):1167-1185. PubMed ID: 34218788
[TBL] [Abstract][Full Text] [Related]
8. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Rudakova EV; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
Bioorg Chem; 2020 Jan; 94():103387. PubMed ID: 31735356
[TBL] [Abstract][Full Text] [Related]
9. β-Carotene: A Natural Compound Improves Cognitive Impairment and Oxidative Stress in a Mouse Model of Streptozotocin-Induced Alzheimer's Disease.
Hira S; Saleem U; Anwar F; Sohail MF; Raza Z; Ahmad B
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31480727
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of transient receptor potential vanilloid subtype 1 (TRPV1) modulator, against behavioral, biochemical and structural damage in experimental models of Alzheimer's disease.
Jayant S; Sharma BM; Sharma B
Brain Res; 2016 Jul; 1642():397-408. PubMed ID: 27084583
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease.
Wang D; Hu M; Li X; Zhang D; Chen C; Fu J; Shao S; Shi G; Zhou Y; Wu S; Zhang T
Eur J Med Chem; 2019 Apr; 168():207-220. PubMed ID: 30822710
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs as Potent Anti-Alzheimer's Agents.
Mahdavi M; Hariri R; Mirfazli SS; Lotfian H; Rastergari A; Firuzi O; Edraki N; Larijani B; Akbarzadeh T; Saeedi M
Chem Biodivers; 2019 Apr; 16(4):e1800488. PubMed ID: 30720917
[TBL] [Abstract][Full Text] [Related]
13. In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer's disease.
Gurjar AS; Darekar MN; Yeong KY; Ooi L
Bioorg Med Chem; 2018 May; 26(8):1511-1522. PubMed ID: 29429576
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel chromenones linked to 1,2,3-triazole ring system: Investigation of biological activities against Alzheimer's disease.
Saeedi M; Safavi M; Karimpour-Razkenari E; Mahdavi M; Edraki N; Moghadam FH; Khanavi M; Akbarzadeh T
Bioorg Chem; 2017 Feb; 70():86-93. PubMed ID: 27914694
[TBL] [Abstract][Full Text] [Related]
15. Organocatalyzed Solvent Free and Efficient Synthesis of 2,4,5-Trisubstituted Imidazoles as Potential Acetylcholinesterase Inhibitors for Alzheimer's Disease.
Pervaiz S; Mutahir S; Ullah I; Ashraf M; Liu X; Tariq S; Zhou BJ; Khan MA
Chem Biodivers; 2020 Mar; 17(3):e1900493. PubMed ID: 31968151
[TBL] [Abstract][Full Text] [Related]
16. Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties.
Cai P; Fang SQ; Yang HL; Yang XL; Liu QH; Kong LY; Wang XB
Eur J Med Chem; 2018 Sep; 157():161-176. PubMed ID: 30096650
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and anti-Alzheimer's activity of novel 1,2,3-triazole-chromenone carboxamide derivatives.
Rastegari A; Nadri H; Mahdavi M; Moradi A; Mirfazli SS; Edraki N; Moghadam FH; Larijani B; Akbarzadeh T; Saeedi M
Bioorg Chem; 2019 Mar; 83():391-401. PubMed ID: 30412794
[TBL] [Abstract][Full Text] [Related]
18. Design and Synthesis of Novel Arylisoxazole-Chromenone Carboxamides: Investigation of Biological Activities Associated with Alzheimer's Disease.
Saeedi M; Rastegari A; Hariri R; Mirfazli SS; Mahdavi M; Edraki N; Firuzi O; Akbarzadeh T
Chem Biodivers; 2020 May; 17(5):e1900746. PubMed ID: 32154628
[TBL] [Abstract][Full Text] [Related]
19. Selenothymidine protects against biochemical and behavioral alterations induced by ICV-STZ model of dementia in mice.
Thomé GR; Oliveira VA; Chitolina Schetinger MR; Saraiva RA; Souza D; Dorneles Rodrigues OE; Teixeira Rocha JB; Ineu RP; Pereira ME
Chem Biol Interact; 2018 Oct; 294():135-143. PubMed ID: 30120923
[TBL] [Abstract][Full Text] [Related]
20. Discovery of potent glycogen synthase kinase 3/cholinesterase inhibitors with neuroprotection as potential therapeutic agent for Alzheimer's disease.
Jiang X; Wang Y; Liu C; Xing C; Wang Y; Lyu W; Wang S; Li Q; Chen T; Chen Y; Feng F; Liu W; Sun H
Bioorg Med Chem; 2021 Jan; 30():115940. PubMed ID: 33340937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
